ENERGIST LIMITED

• ⚠

  Material uncertainty over going concern

  Should the forecast level of sales and profitability not be achieved, the business might need to seek further funding in order to bridge the cashflow position. Should this funding not be available, this represents a material uncertainty which may cast significant doubt about the company's ability to continue as a going concern.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Abridged

Yes — abridged accounts (limited disclosure)

Auditor

Azets Audit Services

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“Should the forecast level of sales and profitability not be achieved, the business might need to seek further funding in order to bridge the cashflow position. Should this funding not be available, this represents a material uncertainty which may cast significant doubt about the company's ability to continue as a going concern.”

Significant events

• “During the year the Company continued to focus on the development of the enhancement of its NeoGen product range, specifically refining the nitrogen plasma technology.”
• “The Company also appointed several new distributors to increase its geographic coverage.”
• “During 2024 the company continued its collaboration with a Dermatological Testing Company, which led to the publishing of a clinical study report, which identified both visible and statistically significant results, including skin density increasing by an average of 80% and cheek wrinkle reduction by 54% following a course of three low to medium energy treatments.”
• “During the year, NeoGen received numerous awards globally, including Skinceuticals Best Energy Device (highly Recommended), The Aesthetic Awards Best Overall Patient Enhancement and Best Non-Surgical Facial Rejuvenation Enhancement, Greece Medical Beauty Most Innovative Device, Safety In Beauty Best Aesthetic Technology Finalist. In February 2025, NeoGen was awarded Best Treatment for Menopause in Aesthetics.”
• “Operationally the company continued to make improvements to the quality of the devices and manufacturing processes.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  —

  Not reported

• Cash

  -23.6%

  £1,004,203 → £767,218

• Net assets

  +15.2%

  £1,291,036 → £1,487,690

  highest in 5 filed years

• Employees

  +16%

  25 → 29

  highest in 5 filed years

• Profit before tax

  -71.8%

  £696,259 → £196,654

• Wages

  +24%

  £1,159,030 → £1,436,788

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers